Bispecific antibody News and Research

RSS
VTT, Dyadic to present data highlighting achievements in development of fungal production platform

VTT, Dyadic to present data highlighting achievements in development of fungal production platform

Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018

Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018

New nuclear medicine approach shows potential for precision treatment of solid tumors

New nuclear medicine approach shows potential for precision treatment of solid tumors

MD Anderson and Amgen collaborate to accelerate early-stage oncology therapies

MD Anderson and Amgen collaborate to accelerate early-stage oncology therapies

Scientists engineer bi-specific antibodies that attract immune killers directly to cancer cells

Scientists engineer bi-specific antibodies that attract immune killers directly to cancer cells

Novel oncolytic virus expressing BiTE molecule elicits T cell-mediated killing of tumor cells

Novel oncolytic virus expressing BiTE molecule elicits T cell-mediated killing of tumor cells

Researchers reveal potential of multivalent antibodies for HIV prevention, treatment and cure

Researchers reveal potential of multivalent antibodies for HIV prevention, treatment and cure

Researchers develop new, three-step system to eliminate colorectal cancer

Researchers develop new, three-step system to eliminate colorectal cancer

Researchers develop new approach to efficiently produce versatile antibody therapies

Researchers develop new approach to efficiently produce versatile antibody therapies

IDIBELL scientists develop oncolytic virus capable of redirecting immune system to attack cancer cells

IDIBELL scientists develop oncolytic virus capable of redirecting immune system to attack cancer cells

Novel Trojan Horse antibody strategy may target Ebola's Achilles' heel

Novel Trojan Horse antibody strategy may target Ebola's Achilles' heel

Immunotherapy innovations in oncology: an interview with Robert LaCaze

Immunotherapy innovations in oncology: an interview with Robert LaCaze

Researchers engineer antibodies that could potently neutralize two deadliest strains of Ebola virus

Researchers engineer antibodies that could potently neutralize two deadliest strains of Ebola virus

F-star signs agreement with AbbVie to discover, develop bispecific antibodies in immuno-oncology

F-star signs agreement with AbbVie to discover, develop bispecific antibodies in immuno-oncology

Immune enters into exclusive license with Atlante Biotech for new format of bispecific antibodies

Immune enters into exclusive license with Atlante Biotech for new format of bispecific antibodies

Amgen gets positive CHMP opinions for Kyprolis (carfilzomib) and BLINCYTO (blinatumomab)

Amgen gets positive CHMP opinions for Kyprolis (carfilzomib) and BLINCYTO (blinatumomab)

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

Xencor announces progress and expansion of proprietary pipeline of XmAb antibodies

Xencor announces progress and expansion of proprietary pipeline of XmAb antibodies

CytomX closes $70 million Series D financing round

CytomX closes $70 million Series D financing round

Merus and Selexis receive a € 2.1 million grant for single cell line manufacturing of a bispecific antibody combination to treat colorectal cancer

Merus and Selexis receive a € 2.1 million grant for single cell line manufacturing of a bispecific antibody combination to treat colorectal cancer